SALEM, N.H., Feb. 23 /PRNewswire/ -- AgaMatrix, Inc., makers of the WaveSense(TM) line of blood glucose monitoring products, announced that it sold its millionth blood glucose meter (BGM). The company shipped its first meter in April 2006. Currently, there are 285 million people with diabetes worldwide, 27 million of which are from the US.(1)
AgaMatrix has 8 FDA-cleared products: the WaveSense KeyNote(TM), KeyNote Pro(TM), Presto(TM), Presto Pro(TM), Amp(TM), WaveSense Jazz(TM), and WaveSense Jazz Wireless(TM) meters, and Zero-Click(TM) software, for data download to a computer. In addition, AgaMatrix was the first BGM maker to launch an App that runs on the iPhone(R) and iPod touch(R). The App is called the WaveSense Diabetes Manager(TM) and is available on the iTunes App Store(R) for free.
“We’re excited that patients and health care professionals have adopted our products so quickly, especially in the last few years when the entire community has become more focused on the importance of accuracy. This tells us we’re focused on the right things - high accuracy and affordable testing,” said Dave Conn, Chief Commercial Officer. “We are looking ahead to selling our 2,000,000th meter soon.”
(C) 2002-2010 AgaMatrix, Inc. WaveSense, KeyNote, KeyNote Pro, Presto, Presto Pro, Amp, WaveSense Jazz, and WaveSense Jazz Wireless, Zero-Click, WaveSense Diabetes Manager are trademarks of AgaMatrix, Inc. Walmart, Kroger, Target, Liberty Medical, Diabetes Care Club, iPhone, iPod touch, and iTunes App Store are registered trademarks of their respective owners.
AgaMatrix, Inc.
